Conneqt Health Limited (ASX: CQT) - Share Price
- Current share price for CQT : $0.020
Conneqt Health Limited's (CQT, formerly Cardiex Limited), an ASX-listed company, mission is to increase longevity through medical technology advancements in vascular health. The Company's suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders, all based on the Company's SphygmoCor vascular biomarker technology.
CQT General Information +
| ASX Code | CQT |
| Website | http://conneqthealth.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 18 |
| CQT Share Price | $0.020 |
| Day High | $0.021 |
| Day Low | $0.020 |
| Last Close | $0.020 |
| CQT Share Price Movement | - ( No change ) |
Prices as at 16:35, 28 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Conneqt Health Limited (CQT) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Conneqt Health Limited (CQT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Conneqt Health Limited (CQT) price-sensitive announcements
CQT - June Quarterly Activities Report
During the June 2026 quarter, CONNEQT Health Limited experienced significant growth across
Conneqt Health Limited (CQT)
21 Jul 2026 | 4:05 PM
21 Jul 2026 | 4:05 PM
CQT - June Quarterly Appendix 4C
CONNEQT Health Limited's Appendix 4C for the quarter ending June 30, 2026, reports on the
Conneqt Health Limited (CQT)
21 Jul 2026 | 4:01 PM
21 Jul 2026 | 4:01 PM
CQT - CQT Announces SPP Launch, Booklet & Timetable
CONNEQT Health Limited announced a Share Purchase Plan (SPP) allowing eligible shareholder
Conneqt Health Limited (CQT)
30 Jun 2026 | 9:29 AM
30 Jun 2026 | 9:29 AM
CQT - CONNEQT Lodges FDA Pre-Submission for SphygmoCor Cloud
CONNEQT Health Limited has lodged an FDA Pre-Submission for their SphygmoCor Cloud, a next
Conneqt Health Limited (CQT)
23 Jun 2026 | 9:27 AM
23 Jun 2026 | 9:27 AM
Conneqt Health Limited (CQT) Recent ASX Announcements
CQT Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$18.19 | -$5.10 | 52.50% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$6.77 | -$3.40 | -76.80% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$18.89 | -$14.50 | 26.00% | 0.00 | 0.00 | 0.00% | 0.0% |
CQT Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Cochlear Limited (COH) | $7,299M | 0.0171 | -0.1894 | 0.0615 | 18.6505 | 23.0086 | 21.6748 | 3.85% | 3.11% | 3.23% |
| Conneqt Health Limited (CQT) | $17M | 0.5252 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $19,193M | 0.1388 | 0.1394 | 0.1883 | 49.4178 | 43.3709 | 36.4977 | 1.33% | 1.42% | 1.61% |
| ResMed Inc. (RMD) | $16,293M | 0.3087 | 9.7744 | 0.0595 | 188.6520 | 17.5093 | 16.5261 | 1.22% | 1.28% | 1.35% |
CQT Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 16.70 | 0.00 |
| Market | 0.30 | 12.80 | 1.13 | 0.58 |
| Sector | 0.67 | 19.60 | 1.55 | 1.65 |
CQT Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Craig Cooper | Chief Executive Officer, Executive Director | 1 Dec 2017 |
| Mr Niall Cairns | Executive Chairman, Executive Director | 20 Dec 2017 |
| Mr Randall King Nelson | Non-Executive Director | 13 Nov 2015 |
| Mr Charlie Taylor | Non-Executive Director | 1 Mar 2024 |
Conneqt Health Limited (CQT) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 25 Jun 2026 | COOPER, Craig | Exercise | Convertibles | 2,000,000 | $1.000 | $2,000,000.000 |
| 25 Jun 2026 | COOPER, Craig | Buy | Indirect Shares | 101,010,102 | $0.020 | $2,000,000.000 |
| 25 Jun 2026 | CAIRNS, Niall | Buy | Indirect Shares | 101,010,102 | $0.020 | $2,000,000.000 |
See all changes in directors' interest & trades for Conneqt Health Limited (CQT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
CQT Management
| Name | Position |
|---|---|
| Louisa Ho | Company Secretary |
CQT Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Conneqt Health Limited (CQT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 222,446,757 (38.69%) | C2 Ventures Pty Ltd |
CQT Calendar of Events
| Date | Event |
|---|---|
| 26 February 2027 | Report (Interim) |
| 01 October 2026 | Report (Prelim) |
| 29 September 2026 | Report (Annual) |
| 28 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
